The US government’s push to dominate quantum computing has handed D-Wave Quantum a powerful near-term catalyst — and a fresh dose of investor conviction. The company sealed a Letter of Intent with the Department of Commerce for $100 million in funding under the CHIPS and Science Act, part of a broader $2 billion initiative backing nine domestic players. The news propelled D-Wave shares to a 13.1% gain on Friday alone, closing at €25.04 and capping a weekly advance of roughly 43%.
Trading volume exploded to around 140 million shares — a 347% surge that underscored the speculative frenzy surrounding the stock. The rally also lifted the broader quantum sector, with Rigetti and IBM riding the same tailwind. D-Wave now carries a market capitalisation of nearly $10.8 billion, a striking figure for a company reporting just $2.9 million in first-quarter revenue.
That revenue figure, down 81% from a year earlier, reflects a tough comparison: the prior-year period included a large system sale that did not repeat. Strip that out, and the underlying story shifts dramatically. Bookings — orders that have not yet converted to revenue — hit a record $33.4 million, a year-over-year jump of nearly 2,000%. The company also signed a $20 million contract with Florida Atlantic University for an Advantage2 quantum computer installation.
On the earnings front, D-Wave posted a loss per share of $0.05, beating analyst expectations by $0.03. The combination of the federal nod and the better-than-anticipated bottom line prompted analysts to adjust their models. The consensus rating stands at “Moderate Buy” with an average price target of $34.67. Needham & Company stood pat at $40, Benchmark at $35, while Rosenblatt sees as high as $43.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Technically, the stock is now trading 56% above its 50-day moving average and 24% above the 200-day line. The relative strength index sits at 47 — still below overbought territory, even after the week’s aggressive rally. The next resistance is the 52-week high of €38.48, a level that now looks within striking distance if momentum holds.
D-Wave’s balance sheet offers some cushion against the revenue volatility. It holds $588 million in cash and marketable securities, sports a liquidity ratio of 21.41, and carries minimal debt with a debt-to-equity ratio of just 0.03. Gross margins are a robust 83%. The company also expanded its technology arsenal with the acquisition of Quantum Circuits, making it a dual-platform provider in the quantum space.
Analyst sentiment is overwhelmingly positive — 13 of the 14 covering analysts rate the stock a buy, with none recommending a sell. TD Cowen characterised D-Wave as one of the biggest beneficiaries of the government’s quantum push.
Yet the central challenge remains the chasm between record bookings and actual recognised revenue. While the $100 million grant provides validation and working capital, it does not immediately close that gap. For investors who loaded up during the week’s 43% surge, the next few quarters will be the true test of whether D-Wave can convert government promises and customer orders into sustainable earnings growth — or whether the rally has simply outpaced the underlying business realities.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from May 23 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 23.
D-Wave Quantum: Buy or sell? Read more here...
